Alcon(US:ALC) ZACKS·2025-11-06 15:16Core Viewpoint - Alcon is expected to report quarterly earnings of $0.77 per share, a decline of 4.9% year-over-year, with revenues projected at $2.59 billion, reflecting a 6.5% increase compared to the previous year [1] Earnings Projections - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1][2] Key Metrics Forecast - Analysts predict 'Net Sales- Total Surgical' to be $1.42 billion, a 6.1% increase from the prior-year quarter [4] - 'Net Sales- Total Vision Care' is expected to reach $1.17 billion, suggesting a 7.1% year-over-year change [4] Detailed Sales Estimates - 'Net Sales- Total Surgical- Consumables' is estimated at $743.89 million, reflecting a 6.1% increase from the previous year [5] - 'Net Sales- Total Surgical- Equipment/other' is projected at $245.51 million, indicating a 14.2% year-over-year increase [5] - 'Net Sales- Total Vision Care- Contact lenses' is expected to be $724.58 million, a 9.1% increase year-over-year [6] - 'Net Sales- Total Vision Care- Ocular health' is forecasted at $448.60 million, showing a 4.1% change from the prior-year quarter [6] Regional Sales Forecast - 'Net Sales- Total Surgical- Implantables' is projected to reach $430.00 million, a 1.9% increase from the previous year [7] - 'Revenues- Other revenues' are expected to be $19.52 million, indicating a 7.1% decline year-over-year [7] - 'Net sales by region- United States' is forecasted at $1.16 billion, reflecting a 4.6% year-over-year increase [7] - 'Net sales by region- International' is expected to reach $1.43 billion, suggesting an 8.2% increase from the prior-year quarter [8] Stock Performance - Alcon shares have decreased by 2.9% in the past month, contrasting with the Zacks S&P 500 composite's increase of 1.3% [8] - With a Zacks Rank 2 (Buy), Alcon is anticipated to outperform the overall market performance in the near term [8]